Conflict of interest register and management
Guideline contents > Conflict of interest
Author(s):
Guidelines commissioned by
Last modified:
7 March 2014 03:45:57
Conflict of interest register and management
Working Party Members were asked to declare in writing, any interests relevant to the guideline development, prior to commencement. Members were asked to update their information if they became aware of any changes to their interests. All declarations were added to a register of interests as listed below.
If Working Party Members were identified as having a significant real or perceived conflict of interest, the Chair could decide that the member either leave the discussion whilst the specific area they were conflicted in was discussed or the member could remain present but not participate in the discussion, or decision making on the specific area where they were conflicted. There were no instances where this occurred during the development of this guideline.
The guidelines have now entered the updating phase. Guideline working party members are responsible to update their conflict of interest statements if a new interest arises. The members will receive a formal reminder to review their statements and ensure it is up-to-date prior to the yearly meetings that will be scheduled to review all updates.
Conflict of interest register
Working party members
| Author | Conflict of interest declaration |
|---|---|
| Dr Alison Brand (Chair)
Gynaecological Oncologist – Westmead Hospital, Sydney NSW |
No conflict of interest to declare |
| Professor Ian Hammond (Deputy Chair)
Gynaecological Oncologist, Cancer Australia Advisory Group/ King Edward Memorial Hospital, Perth WA |
No conflict of interest to declare |
| Dr Robyn Cheuk
Radiation Oncologist, Cancer Australia Advisory Group/ Royal Brisbane and Womens Hospital, Brisbane QLD |
No conflict of interest to declare |
| Kathryn Crisell
Gynaecological cancer consumer, Adelaide SA |
No conflict of interest to declare |
| Assoc Professor Margaret Davy
Gynaecological Oncologist, Cancer Australia Advisory Group/ Royal Adelaide Hospital, Adelaide SA |
Has been a member of the GSK Advisory Board for Cervarix and also given lectures sponsored by GSK and CSL |
| Dr Andrew Dean
Medical Oncologist, St John of God Hospital, Perth WA |
Has been on an Advisory Board for Specialised Therapeutics Australia and received an honorarium from them |
| Dr Louise Farrell
Gynaecologist, King Edward Memorial Hospital, Perth WA |
Has received sponsorship to attend meetings from GSK, MSD and CSL. Has received a grant from GSK to run a survey of Gynaecologists’ attitude to HPV vaccines. Is an investigator in both CSL and GSK HPV vaccine trials |
| Jane Francis
Manager, Gynaecological Cancers, Cancer Australia |
No conflict of interest to declare |
| Clinical Associate Professor Russell Hogg
Gynaecological Oncologist, Westmead Hospital, Sydney NSW |
No conflict of interest to declare |
| Lesley McQuire
Gynaecological cancer consumer, Sydney NSW |
No conflict of interest to declare |
| Dr Selvan Pather
Gynaecological Oncologist, Royal Prince Alfred Hospital, Sydney NSW |
No conflict of interest to declare |
| Dr Frances Quirk
Sexologist, Townsville QLD |
No conflict of interest to declare |
| Dr Felicity Rea
General Practitioner, Toowoomba QLD |
No conflict of interest to declare |
| Dr Colin Stewart
Histopathologist, WA |
No conflict of interest to declare |
| Ella Curnow
Project Officer - Cancer Australia |
No conflict of interest to declare |
| Professor Ian Olver AM (Convenor)
CEO - Cancer Council Australia |
No conflict of interest to declare |
| Christine Vuletich
Manager - Clinical Guidelines Network, Cancer Council Australia |
No conflict of interest to declare |
| Alice Winter-Irving
Project Officer - Clinical Guidelines Network, Cancer Council Australia |
No conflict of interest to declare |
| Jutta von Dincklage
Project Manager - Wiki Development, Cancer Council Australia |
No conflict of interest to declare |
Contributing authors
| Author | Conflict of interest declaration |
|---|---|
| Dr Linda Mileshkin
Medical Oncologist, Peter MacCallum Cancer Centre Melbourne VIC |
Australian PI for ANZGOG international PORTEC 3 trial. Hospira is supplying paclitaxel for Australian patients in this trial. |
| Dr Marcelo C Nascimento
Gynaecological Oncologist, Mater Hospital and Gold Coast Hospital, QLD |
No conflict of interest to declare |
| Professor Andreas ObermairGynaecological Oncologist, Queensland Centre for Gynaecological Cancer, The University of Queensland, Brisbane QLD | Has received sponsorship to attend conferences from Gate Health who market the McCartney tube |
| Dr Kym Reid
Gynaecological Oncology Fellow, Brisbane QLD |
No conflict of interest to declare |
| Dr Colin Stewart
Histopathologist, St John of God Pathology, Perth WA |
No conflict of interest to declare |
| Ai Ling Tan
Gynaecological Oncologist Auckland, New Zealand |
Involved in a trial as an investigator sponsored by GSK
Prevalance of HPV16,18 in cervical cancer in NZ women |